| Literature DB >> 24689484 |
Shane M Wilkinson1, Hendra Gunosewoyo, Melissa L Barron, Aurelie Boucher, Michelle McDonnell, Peter Turner, Daniel E Morrison, Maxwell R Bennett, Iain S McGregor, Louis M Rendina, Michael Kassiou.
Abstract
Relative to other polycyclic frameworks (1-3), a carborane cage (4 and Cs·5) exerts a significant biological effect as an inhibitor of the purinergic P2X7 receptor (P2X7R) which allows one to target depression in vivo and thus demonstrate, for the first time, that a carborane has the capacity to modify CNS activity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24689484 PMCID: PMC4030799 DOI: 10.1021/cn500054n
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418